Standard BioTools

Standard BioTools is a biotech tools company that creates microfluidic-based chips and instrumentation for biological research.

Business Model:

Revenue: $0

Employees: 201-500

Detailed Standard BioTools Information

Geographic Data

Standard BioTools headquarters map

Address:

City: South San Francisco

State: California

Zip:

Country: United States

Financial Info

Stage:

post ipo equity

Raised Last:

$250M

Raised Total:

$375M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Standard BioTools, previously known as Fluidigm, is driven by a bold vision – unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the Company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.

Contact Phone:

Contact Email:

Standard BioTools went public on 2/10/2011 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/10/2011

Ticker Symbol:
LAB

IPO Price:
$13.5/share

Amount Raised:
$75M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2005 Series D $0 EuclidSR Partners
Versant Ventures
InterWest Partners
EuclidSR Partners
Versant Ventures
InterWest Partners
1/2011 Debt Financing $5M
9/2009 Venture Round $10.7M
11/2009 Venture Round $0 Lehman Brothers
Alloy Ventures
EuclidSR Partners
InterWest Partners
Fidelity Contrafund
Smallcap World Fund
Versant Ventures
EDBI
Lehman Brothers
Alloy Ventures
EuclidSR Partners
InterWest Partners
Fidelity Contrafund
Smallcap World Fund
Versant Ventures
EDBI
1/2004 Series D 5 $21M EDBI
Invus
Versant Ventures
Lehman Brothers
InterWest Partners
EDBI
Invus
1/2007 Series E $0 Cross Creek
Wasatch Advisors
Alloy Ventures
EDBI
EuclidSR Partners
InterWest Partners
Lilly Ventures
Versant Ventures
Cross Creek
Wasatch Advisors
Alloy Ventures
EDBI
EuclidSR Partners
InterWest Partners
Lilly Ventures
Versant Ventures
11/2001 Series C 6 $34M Lehman Brothers
Versant Ventures
Piper Jaffray
InterWest Partners
GE Equity
EuclidSR Partners
Lehman Brothers
1/2022 Post-IPO Equity $0 Casdin Capital
Viking Global Investors
Casdin Capital
Viking Global Investors
1/2022 Post-IPO Equity 2 $250M Casdin Capital
Viking Global Investors
Casdin Capital
Viking Global Investors
11/2009 Venture Round 8 $7.5M Lehman Brothers
Alloy Ventures
EuclidSR Partners
InterWest Partners
Fidelity Contrafund
Smallcap World Fund
Versant Ventures
EDBI
Lehman Brothers
Alloy Ventures
EuclidSR Partners
InterWest Partners
Fidelity Contrafund
Smallcap World Fund
Versant Ventures
EDBI
1/2007 Series E 8 $37M Cross Creek
Wasatch Advisors
Cross Creek
Wasatch Advisors
9/2005 Series D 3 $10M
Announced Date Name Price
1/2014 DVS Sciences

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research